Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Non Operating Income (2023 - 2025)

Historic Non Operating Income for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $7.3 million.

  • CG Oncology's Non Operating Income fell 721.17% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 2357.18%. This contributed to the annual value of $26.6 million for FY2024, which is 28916.98% up from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Non Operating Income is $7.3 million, which was down 721.17% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Non Operating Income registered a high of $7.9 million during Q3 2024, and its lowest value of $713000.0 during Q2 2023.
  • Moreover, its 3-year median value for Non Operating Income was $6.3 million (2024), whereas its average is $5.1 million.
  • In the last 5 years, CG Oncology's Non Operating Income soared by 87489.48% in 2024 and then crashed by 721.17% in 2025.
  • CG Oncology's Non Operating Income (Quarter) stood at $2.8 million in 2023, then surged by 123.25% to $6.3 million in 2024, then rose by 17.12% to $7.3 million in 2025.
  • Its last three reported values are $7.3 million in Q3 2025, $7.3 million for Q2 2025, and $7.8 million during Q1 2025.